FDA Clearance Tracker · P030035-S208
Anthem, Allure/RF, Allure Quadra/RF family of CRT-Ps
Last checked: Nov 20, 2026Latest source record: Jun 17, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jun 17, 2025
Approved
Time to decision
90 days
Received Mar 19, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P030035-S208
- Device name
- Anthem, Allure/RF, Allure Quadra/RF family of CRT-Ps
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- Mar 19, 2025
- Decided
- Jun 17, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P030035
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for the AVEIR AR 2 LSP203A Leadless Pacemaker (LP), including updates to LP design, labeling, and Merlin PCS Programmer Software 3330 v28.5.x.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.